Enhancing Hepatitis C Testing And Treatment Among People Who Inject Drugs In Drug Treatment Settings: The ETHOS III Study
Funder
National Health and Medical Research Council
Funding Amount
$1,349,604.00
Summary
Progress towards hepatitis C elimination has been slowed. Given that most people with hepatitis C have a history of injecting drug use, reducing hepatitis C burden requires scale-up of enhanced testing and treatment for people who inject drugs. This Partnership project will evaluate an intervention to enhance hepatitis C testing and treatment in drug treatment clinics and develop a translational framework to scale-up hepatitis C care in this setting nationally.